Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices. Medical and ...

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

SYK's fourth-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to ...

Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term ...

From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22.

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...